Fact sheet: Woodford PatientCapTrt

Fund information

Fund name
Woodford Patient Capital Trust PLC ORD 1P
Fund company manager
Woodford Investment Management
Fund type
ITR
Fund manager(s)
Neil Woodford
since 21/04/2015
Fund objective
To achieve long-term capital growth through investing in a portfolio consisting predominantly of UK companies, both quoted and unquoted. The Company will aim to deliver a return in excess of 10% per annum over the longer term.
Benchmark
-
Investment style
Growth
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

-5.17 %

1 Year rank in sector

14/15

Sector

IT UK All Companies

Yield
-
Fund size

£ 736.0 m

FE Risk score

150

NAV

94.51

Discount/Premium

+-5.8301

Gearing

118

Top in sector

Holdings snapshot

  • UK
    85.77%
  • USA
    24.71%
  • Norway
    3.16%
  • Ireland
    1.92%
  • Switzerland
    0.93%
  • Health Care
    67.61%
  • Financials
    26.97%
  • Technology
    12.13%
  • Industrials
    6.55%
  • Telecommunications
    2.69%
  • UK Equities
    85.77%
  • US Equities
    24.71%
  • Norwegian Equities
    3.16%
  • Irish Equities
    1.92%
  • Swiss Equities
    0.93%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund-3.05 %-3.73 %-5.17 %0 %0 %
Sector-0.24 %1.09 %19.3 %29.34 %76.03 %
Rank within sector13 / 1512 / 1514 / 15 / /
Quartile th4 th4 th4 th th th

Calendar performance

YTD-20172016201520142013
Fund-2.2 %-9.75 %0 %0 %0 %
Sector14.65 %3.81 %9.09 %-1.69 %31.32 %
Rank within sector13 / 1514 / 15 / / /
Quartile th4 th4 th th th th

Price movement

52 week high106
52 week low87.75
Current bid price88.5
Current offer price89.05
Current mid price89

Holdings by region

  • 85.77% UK
  • 24.71% USA
  • 3.16% Norway
  • 1.92% Ireland
  • 0.93% Switzerland
  • 0.53% Luxembourg
  • -17.02% Money Market

Holdings by sector

  • 67.61% Health Care
  • 26.97% Financials
  • 12.13% Technology
  • 6.55% Industrials
  • 2.69% Telecommunications
  • 0.83% Consumer Goods
  • 0.24% Basic Materials
  • -17.02% Money Market

Holdings by asset type

  • 85.77% UK Equities
  • 24.71% US Equities
  • 3.16% Norwegian Equities
  • 1.92% Irish Equities
  • 0.93% Swiss Equities
  • 0.53% Luxembourg Equities
  • -17.02% Money Market

Individual holdings

  • 16.33% PROTHENA CORP PLC
  • 8.63% OXFORD NANOPORE
  • 8.24% PURPLEBRICKS GROUP PLC
  • 7.34% IMMUNOCORE A (UNQUOTED)
  • 5.83% BENEVOLENT AI (UNQUOTED)
  • 5.34% AUTOLUS (UNQUOTED)
  • 4.35% THERAVANCE BIOPHARMA INC
  • 4.12% PROTON PARTNERS INTERNATIONAL (UNQUOTED)
  • 4.09% MEREO BIOPHARMA GROUP LTD
  • 3.3% OXFORD SCIENCES INNOVATION ORD NPV